tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sudan Loganathan, 47 are a BUY (79.66%), 12 are a HOLD (20.34%).
Analyst Sudan Loganathan, currently employed at STEPHENS, carries an average stock price target met ratio of 13.43% that have a potential upside of 23.23% achieved within 35 days.
Sudan Loganathan’s has documented 117 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARVN, Arvinas at 03-Jun-2026.
Analyst best performing recommendations are on SNSE (SENSEI BIOTHERAPEUTICS).
The best stock recommendation documented was for SNSE (SENSEI BIOTHERAPEUTICS) at 6/30/2025. The price target of $35 was fulfilled within 239 days with a profit of $26.42 (307.93%) receiving and performance score of 12.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Mar-2026
$21
$13.59 (183.40%)
$24
1 months 23 days ago
(10-Aug-2026)
8/20 (40%)
$12.01 (133.59%)
106
Buy Since 25-Feb-2026
$14
$6.59 (88.93%)
$19
1 months 23 days ago
(10-Aug-2026)
0/2 (0%)
$5.01 (55.73%)
Hold Since 18-Sep-2025
$12
$4.59 (61.94%)
$11
1 months 28 days ago
(05-Aug-2026)
12/19 (63.16%)
$3.6 (42.86%)
126
Buy Since 09-May-2024
$11
$3.59 (48.45%)
$15
1 months 28 days ago
(05-Aug-2026)
1/9 (11.11%)
$2.6 (30.95%)
399
Buy Since 12-Mar-2025
$18
$10.59 (142.91%)
$18
1 months 29 days ago
(04-Aug-2026)
0/6 (0%)
$9 (100.00%)
Which stock is Sudan Loganathan most bullish on?
Which stock is Sudan Loganathan most reserved on?
What Year was the first public recommendation made by Sudan Loganathan?
